A noninvasive stimulation technique targeting specific brain regions resulted in month-long memory improvements in seniors who participated in a recent study.

NIH researchers have found that dual bronchodilators—long-lasting inhalers that relax the airways and make it easier to breathe—do little to help people who have respiratory symptoms related to smoking but who do not have chronic obstructive pulmonary disease (COPD).

NIH researchers have found that a novel blood test can easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability. PAH is a rare, life-threatening condition that causes unexplained high blood pressure in the lungs.

A prospective study of a half-million tea drinkers in the United Kingdom has shown that higher tea intake was associated with a modestly lowered risk of death.

In a new study, NIAID researchers analyzed levels of SARS-CoV-2 antigen in blood samples taken from study participants and assessed the association of those levels with disease progression.

ne injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a NIAID phase 1 clinical trial.

Ultrasound is a noninvasive technique that lets clinicians peer inside the body to monitor health or diagnose disease. Several research groups have been trying to develop approaches that would allow longer-term ultrasound monitoring in various settings via wearable devices.

A new NIH study found that biomarkers present in the blood on the day of a traumatic brain injury (TBI) can accurately predict a patient’s risk of death or severe disability 6 months later.

Research has long supported the notion that music and other kinds of sound can help alleviate acute and chronic pain. In a new study, published in Science, an international team of scientists used mice to explore neural pathways through which sound blunts pain.

Using a new imaging technique, NEI researchers have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases.